Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury
Brain Injury
About this trial
This is an interventional treatment trial for Brain Injury focused on measuring Brain Injury, Neuropsychology, Cognitive Behavioral Therapy, Neuropsychological Rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Having suffered an acquired brain injury after the age of 14, such as traumatic brain injury, neoplasm (after surgery), toxic brain damage, or brain damages through inflammatory diseases
- Being at least 3 months post injury
- Being German-speaking
- Agreeing to participate, verified by completion of informed consent
Exclusion Criteria:
- Suffering from recurrent, degenerative, or progressive neurological diseases (e.g. multiple sclerosis, dementia, Chorea Huntington)
- Current or past psychosis or bipolar disorder
- Current or past diagnosis of substance dependency
- History of mental retardation
- Currently in psychotherapy
- Severe lateralized disorder (e.g. aphasia, neglect)
- Lacking minimum basic skills for attending therapy (e.g. not orientated to person, place, time, and events; unable to sustain attention for an hour-long session; cannot state cognitive strengths and weaknesses; cannot state areas in everyday functioning that are impaired due to the acquired brain injury)
Sites / Locations
- Philipps University Marburg, Departement of Clinical Psychology and Psychotherapy
- Psychotherapie-Ambulanz Marburg
Arms of the Study
Arm 1
Arm 2
Experimental
Other
1
2
Neuropsychological cognitive behavioral psychotherapy for patients with acquired brain injury consists of 25 weekly 1-hr sessions of individualized outpatient treatment. The therapeutical intervention is modularised, patients are assigned to specific interventional modules according to the results of cognitive testing and interviews. Modules concern on the one hand the treatment of deficits in attention, memory, and executive functions. On the other hand psychosocial adjustment to chronic illness is addressed through modules that concern the development of a positive self-concept, the adjustment of life-goals and coping with negative affect (e.g. depressive symptoms, irritability, guilt).
Waiting list: Patients are randomly assigned to one of two existing groups after completion of the first session of various neuropsychological tests and interviews. Patients assigned to the experimental group receive therapy immediately after completing the first session of various neuropsychological tests and interviews. Patients randomized to the waiting list receive the treatment as specified above after waiting for 5 month.